The prognostic model of Ewing's sarcoma constructed using GCLE and TPI1 indicated that survival of the high-risk group is much lower than that of the low-risk group and that GCLE and TPI1 can serve as prognostic biomarkers for Ewing's sarcoma. The gene discussed is TPI1; the disease is Ewing sarcoma.